Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 217495
Company: XIROMED
Company: XIROMED
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER;INTRAVENOUS | Prescription | AP | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 11/29/2024 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
LEVOTHYROXINE SODIUM
POWDER;INTRAVENOUS; 100MCG/VIAL
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER;INTRAVENOUS | Prescription | Yes | AP | 202231 | FRESENIUS KABI USA |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER;INTRAVENOUS | Prescription | No | AP | 208749 | MAIA PHARMS INC |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER;INTRAVENOUS | Prescription | No | AP | 216729 | ONESOURCE SPECIALTY |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER;INTRAVENOUS | Prescription | No | AP | 206163 | PIRAMAL CRITICAL |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER;INTRAVENOUS | Prescription | No | AP | 217495 | XIROMED |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER;INTRAVENOUS | Prescription | No | AP | 217066 | ZYDUS PHARMS |